The CASPR2 cell adhesion molecule functions as a tumor suppressor gene in glioma

Linda Bralten, Lonneke Gravendeel, Nanne Kloosterhof, Andrea Sacchetti, T Vrijenhoek, JA Veltman, Martin van den Bent, J.M. Kros, CC Hoogenraad, Peter Sillevis Smitt, Pim French

Research output: Contribution to journalArticleAcademicpeer-review

23 Citations (Scopus)

Abstract

Genomic translocations have been implicated in cancer. In this study, we performed a screen for genetic translocations in gliomas based on exon-level expression profiles. We identified a translocation in the contactin-associated protein-like 2 (CASPR2) gene, encoding a cell adhesion molecule. CASPR2 mRNA was fused to an expressed sequence tag that likely is part of the nuclear receptor coactivator 1 gene. Despite high mRNA expression levels, no CASPR2 fusion protein was detected. In a set of 25 glioblastomas and 22 oligodendrogliomas, mutation analysis identified two additional samples with genetic alterations in the CASPR2 gene and all three identified genetic alterations are likely to reduce CASPR2 protein expression levels. Methylation of the CASPR2 gene was also observed in gliomas and glioma cell lines. CASPR2-overexpressing cells showed decreased proliferation rates, likely because of an increase in apoptosis. Moreover, high CASPR2 mRNA expression level is positively correlated with survival and is an independent prognostic factor. These results indicate that CASPR2 acts as a tumor suppressor gene in glioma. Oncogene (2010) 29, 6138-6148; doi:10.1038/onc.2010.342; published online 16 August 2010
Original languageUndefined/Unknown
Pages (from-to)6138-6148
Number of pages11
JournalOncogene
Volume29
Issue number46
DOIs
Publication statusPublished - 2010

Cite this